Centogene (CNTG)
(Delayed Data from NSDQ)
$0.36 USD
-0.02 (-5.55%)
Updated Jun 4, 2024 03:56 PM ET
After-Market: $0.36 0.00 (-1.21%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Income Statements
Fiscal Year end for Centogene NV falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 53 | 50 | 225 | 147 | 55 |
Cost Of Goods | 34 | 29 | 191 | 99 | 29 |
Gross Profit | 19 | 21 | 33 | 48 | 26 |
Selling & Adminstrative & Depr. & Amort Expenses | 51 | 60 | 88 | 70 | 46 |
Income After Depreciation & Amortization | -32 | -39 | -54 | -23 | -21 |
Non-Operating Income | 3 | 3 | 0 | 0 | 0 |
Interest Expense | 9 | 5 | 1 | 2 | 2 |
Pretax Income | -38 | -41 | -55 | -24 | -23 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -39 | -41 | -55 | -24 | -23 |
Extras & Discontinued Operations | 0 | 7 | 0 | 0 | 0 |
Net Income (GAAP) | -39 | -34 | -55 | -24 | -23 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -24 | -28 | -29 | -5 | -14 |
Depreciation & Amortization (Cash Flow) | 8 | 11 | 25 | 17 | 7 |
Income After Depreciation & Amortization | -32 | -39 | -54 | -23 | -21 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 27.98 | 26.82 | 22.44 | 20.91 | 14.11 |
Diluted EPS Before Non-Recurring Items | -1.37 | -1.53 | -2.44 | -1.17 | -1.46 |
Diluted Net EPS (GAAP) | -1.38 | -1.25 | -2.44 | -1.17 | -1.46 |
Fiscal Year end for Centogene NV falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |